Atlas Trials

Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance

Clinical trial NCT00085982 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00085982
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Insulin Resistance
Start date
2003-08-21
Primary completion
2019-10-23
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.